| |
His early studies of the effects of growth factors on
cultured cells evolved into a gene discovery program, focusing
on genes that show a rapid response to a growth stimulus
provided by, for example, a tumor promoter. Among the "early
response" genes that he discovered was a novel prostaglandin
cyclooxygenase gene, subsequently adopted by the pharmaceutical
industry for development of a major drug.
Most recently Dr. Herschman set out to develop a technique
that would permit non-invasive and repetitive tracking of genes
introduced into animals (and eventually into people, in the
course of somatic gene therapy). In close collaboration with the
distinguished positron emission tomography (PET) group at UCLA,
he succeeded in devising such a gene imaging technology. Thus
his basic studies of biochemistry, molecular and cell biology
have expanded into areas of pharmacology and molecular
medicine.
|